News

AbbVie Secures FDA Approval to Expand Mavyret’s Label
AbbVie Inc. (NYSE:ABBV) is one of the best stocks for a dividend stock portfolio. The company announced that the US FDA has ...
GlobalData on MSN3d
FDA approves label expansion of AbbVie hepatitis C therapy
The US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir) for treating adults and paediatric patients three years and older with acute ...
Targeted Oncology3d
FDA Greenlights Perioperative Pembrolizumab in Resectable HNSCC
The FDA has granted approval to pembrolizumab for the treatment of adult patients with resectable, locally advanced HNSCC ...
Pharmabiz3d
AbbVie’s Mavyret receives US FDA label expansion approval for treatment of chronic hepatitis C virus
AbbVie’s Mavyret receives US FDA label expansion approval for treatment of chronic hepatitis C virus: North Chicago Saturday, June 14, 2025, 11:00 Hrs [IST] AbbVie announced tha ...
MedPage Today on MSN4d
Polypill Approved for Hypertension, Including as Initial Therapy
The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...
MPR16h
Brukinsa Tablets Get FDA Nod for All Approved Indications
The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.
Medical Dialogues16h
FDA Approves Keytruda as First Immune Checkpoint Inhibitor for Resectable Locally Advanced Head and Neck Cancer
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...
Managed Healthcare Executive3d
FDA Approves Ibtrozi For Adults With ROS1+ NSCLC
Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell ...
First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...
News-Medical.Net on MSN1d
FDA approval of pembrolizumab marks major shift in head and neck cancer treatment
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...
Pharmaceutical Technology on MSN3d
Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults
The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.